Answers are grounded in this paper and cite their sources.
An innovative, straightforward, sustainable, and sensitive fluorescent turn off–on sensing probe was developed for quick assay of tobramycin. Tobramycin (TBM) is one of aminoglycosides, which is frequently utilized for the management of gram negative bacterial infections. Developing an analytical procedure for the assay of TBM is challenging due to its structure that lacks chromophore. This study aims to establish a sensing strategy that relies on the quenching of the of fluorescence of salicylate at 410 nm upon the addition of ammonium ferric sulfate after excitation at 299 nm. The capability of tobramycin to displace salicylate from ferric salicylate complex results in turning on salicylate fluorescence. Box–Behnken design (BBD) was selected for efficient optimization of the key experimental factors. A linear response was achieved throughout concentrations of TBM ranging from 6.0 to 30.0 μg/mL (equivalent to 12.8–64.2 µM) with limits of detection and quantitation equal 1.26 μg/mL and 3.81 μg/mL, respectively. The proposed probe was implemented for analysis of TBM in eye drops with mean percent recovery of 99.72 % ± 1.11. The ecological friendliness of the developed platform was proved according to several metrics for whiteness, blueness, and greenness. Moreover, compliance with many sustainability development goals (SDGs) was evidenced.
No takes yet. Share an insight, caveat, or question.
Alabdulmonem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: